Final versions of the summary of consultation findings and an integrated health inequalities and equality impact assessment (IIA) of the proposal have been published.

The documents are available on the Consultation documents page.

The consultation, which ran between 24 May and 16 September 2019, gave patients, staff and the general public the opportunity to comment on the proposal to create a new centre for eye care, research and education in the St Pancras area.

We received around 4,600 contributions during the consultation through various ways including discussion groups, emails, phone calls and the consultation survey.

A draft version of the consultation findings report was published at the end of October 2019 which gave people the opportunity to review the feedback and feed in any comments that they think may have been missed. This feedback has been incorporated into the final version of the report.

The independent analysis of the survey results tell us that 73% of respondents agree that a new centre is needed and 73% agree with St Pancras as the preferred location.

Next steps

31 January 2020 – North Central London Joint Health Overview and Scrutiny Committee (JHOSC) to consider the proposal and view on the public consultation process. Find out more about this event.

12 February 2020 – NHS England Specialised Commissioning and a CCGs’ Committees in Common to consider the outcome of the consultation and the Decision Making Business Case. The outcome of this meeting will determine whether Moorfields, UCL and Moorfields Eye Charity can continue to the next stage of planning. Find out more about this event.

Copies of the findings summary, people with protected characteristics and the IIA are available on the Consultation documents page. If you would like these documents in another format, contact the consultation team by emailing or calling 020 7521 4684.

Want to remain updated with the latest news about Oriel?

Email the consultation team and request to join our Oriel mailing list for up-to-date news and developments.